<p>The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.</p>

Subscribe

Title Date published
BoB@JPM: Peter Anastasiou, Capsida Biotherapeutics 2025-02-10
BoB@JPM: Stefan Scherer, M.D., Ph.D., 3T Bioscience 2025-02-03
The Business Of CNS with Acumen's Jim Doherty, Ph.D. 2025-01-27
High-Throughput Discovery With Bioptic's Andrey Dobry 2025-01-20
RNA Sandbox with Johns Hopkins RNA Innovation Center's Jeff Coller, Ph.D. and Michelle Kim, Ph.D. 2025-01-13
Biotech Story Time With Tal Zaks, M.D. (Part 2, Tall Tales with Tal) 2025-01-06
Risk Mitigation With Meira GTx's Zandy Forbes, Ph.D. 2024-12-30
Biotech Story Time With Tal Zaks, M.D. (Part 1) 2024-12-23
A $1B AI Bet With Foresite Labs' Vik Bajaj, Ph.D. 2024-12-16
Manufacturing Partnership With Life Biosciences' Jerry McLaughlin and Forge Biologics' John Maslowski 2024-12-09
Novel Peptide Delivery With Revolo's Woody Bryan, Ph.D. 2024-12-02
Biopolitics With Allan Shaw 2024-11-25
T-Cells For The Win With Adaptimmune's Adrian Rawcliffe 2024-11-18
Serving The Underserved With Gates MRI's Claire Wagner, M.D. 2024-11-11
An Unanticipated Biotech Startup With OS Therapies' Paul Romness 2024-11-04
Building On Pandemic Progress With Barinthus Biotherapeutics' Bill Enright 2024-10-28
Obesity Tx End-Around With Skye Bioscience's Punit Dhillon 2024-10-21
Biotech C-Suite Construction With Allan Shaw 2024-10-14
The Peptide Promise With NervGen's Mike Kelly 2024-10-07
Biotech Course Correction With Treehill Partners' Ali Pashazadeh 2024-09-30
1234567891011121314

Comments about Business Of Biotech

comments powered by Disqus
Advertisment: